# China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

Study · id `cardio:ct-nct04974151` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04974151](<https://clinicaltrials.gov/study/NCT04974151>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04974151

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: High blood pressure; Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 24000 participants.

## Technical summary

Registry record NCT04974151. Randomized; quadruple masking; primary purpose treatment. Start 2024-08-22 (actual); primary completion 2029-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 24000 participants (planned count; ClinicalTrials.gov record NCT04974151, source copy `cardio:ctgov-nct04974151-2025-02-26`, retrieved 2026-10-26)
- Started: 2024-08-22 (actual) (ClinicalTrials.gov record NCT04974151, source copy `cardio:ctgov-nct04974151-2025-02-26`, retrieved 2026-10-26)
- Primary completion: 2029-06-30 (anticipated) (ClinicalTrials.gov record NCT04974151, source copy `cardio:ctgov-nct04974151-2025-02-26`, retrieved 2026-10-26)
- Completion: 2029-06-30 (anticipated) (ClinicalTrials.gov record NCT04974151, source copy `cardio:ctgov-nct04974151-2025-02-26`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04974151, source copy `cardio:ctgov-nct04974151-2025-02-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04974151-2025-02-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
- Acronym: CSPPT2-TT
- Condition: Hypertension
- Condition: MTHFR 677 TT Genotype
- Intervention (Drug): Amlodipine besylate
- Intervention (Drug): Amlodipine besylate And Folic Acid
- Intervention (Drug): 5-methyltetrahydrofolate (5-MTHF)
- Intervention (Drug): Amlodipine placebo
- Intervention (Drug): Amlodipine folic acid placebo
- Intervention (Drug): 5-MTHF Placebos
- Lead sponsor: Shenzhen Ausa Pharmed Co.,Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Peking University First Hospital
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital of Nanchang University
- Collaborator class: OTHER
- Collaborator: The First People's Hospital of Lianyungang
- Collaborator class: OTHER
- Collaborator: The Affiliated Hospital Of Guizhou Medical University
- Collaborator class: OTHER
- Collaborator: Lianyungang Oriental Hospital
- Collaborator class: OTHER
- Collaborator: Tengzhou Central People's Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: The First Affiliated Hospital of Bengbu Medical University
- Collaborator class: OTHER
- Collaborator: Shenzhen Prospective Medical Technology Co., LTD
- Collaborator class: UNKNOWN
- Collaborator: Weinan Central Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
- Collaborator class: OTHER
- Collaborator: Loudi Central Hospital
- Collaborator class: OTHER
- Collaborator: Yancheng First People's Hospital
- Collaborator class: OTHER
- Collaborator: TAIHE country people's hospital
- Collaborator class: UNKNOWN
- Collaborator: First Affiliated Hospital of Gannan Medical University
- Collaborator class: OTHER
- Collaborator: Yangjiang People's Hospital
- Collaborator class: OTHER
- Collaborator: Deyang People's Hospital
- Collaborator class: OTHER
- Collaborator: Bozhou people's hospital
- Collaborator class: UNKNOWN
- Collaborator: Chizhou people's hospital
- Collaborator class: UNKNOWN
- Collaborator: Lianyungang Second People's Hospital
- Collaborator class: UNKNOWN
- Collaborator: The Affiliated Hospital Of Southwest Medical University
- Collaborator class: OTHER
- Collaborator: Chengdu Fifth People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 13 registry organizations

## Provenance

Content hash: 04036adb69572b2ca1d36469dd07f06758fbf2e9e61006f6ddccc40427755d63
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
